Literature DB >> 20428942

Serum pepsinogens in gastric cancer screening.

Pelayo Correa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20428942      PMCID： PMC3143021          DOI： 10.1007/s10620-010-1248-8

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  24 in total

1.  Carcinoma and intestinal metaplasia of the stomach in Colombian migrants.

Authors:  P Correa; C Cuello; E Duque
Journal:  J Natl Cancer Inst       Date:  1970-02       Impact factor: 13.506

2.  Gastric carcinoma risk index in patients infected with Helicobacter pylori.

Authors:  A Meining; E Bayerdörffer; P Müller; S Miehlke; N Lehn; D Hölzel; R Hatz; M Stolte
Journal:  Virchows Arch       Date:  1998-04       Impact factor: 4.064

3.  Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia.

Authors:  I M Samloff; K Varis; T Ihamaki; M Siurala; J I Rotter
Journal:  Gastroenterology       Date:  1982-07       Impact factor: 22.682

4.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

5.  Prescreening of a high-risk group for gastric cancer by serologically determined Helicobacter pylori infection and atrophic gastritis.

Authors:  Shigeto Mizuno; Ikuya Miki; Tsukasa Ishida; Masaru Yoshida; Mitsuko Onoyama; Takeshi Azuma; Yasuki Habu; Hideto Inokuchi; Kotaro Ozasa; Kazumasa Miki; Yoshiyuki Watanabe
Journal:  Dig Dis Sci       Date:  2010-03-04       Impact factor: 3.199

6.  Implications of serum pepsinogen I in early endoscopic diagnosis of gastric cancer and dysplasia. Helsinki Gastritis Study Group.

Authors:  K Varis; P Sipponen; F Laxén; I M Samloff; J K Huttunen; P R Taylor; O P Heinonen; D Albanes; N Sande; J Virtamo; M Härkönen
Journal:  Scand J Gastroenterol       Date:  2000-09       Impact factor: 2.423

7.  Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening.

Authors:  M Dinis-Ribeiro; G Yamaki; K Miki; A Costa-Pereira; M Matsukawa; M Kurihara
Journal:  J Med Screen       Date:  2004       Impact factor: 2.136

Review 8.  Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994.

Authors:  M F Dixon; R M Genta; J H Yardley; P Correa
Journal:  Am J Surg Pathol       Date:  1996-10       Impact factor: 6.394

9.  Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer.

Authors:  Hiroshi Ohata; Shintaro Kitauchi; Noriko Yoshimura; Kouichi Mugitani; Masataka Iwane; Hideya Nakamura; Akiyoshi Yoshikawa; Kimihiko Yanaoka; Kenji Arii; Hideyuki Tamai; Yasuhito Shimizu; Tatsuya Takeshita; Osamu Mohara; Masao Ichinose
Journal:  Int J Cancer       Date:  2004-03       Impact factor: 7.396

10.  A model for gastric cancer epidemiology.

Authors:  P Correa; W Haenszel; C Cuello; S Tannenbaum; M Archer
Journal:  Lancet       Date:  1975-07-12       Impact factor: 79.321
View more
  9 in total

1.  Pepsinogen-II 100 bp ins/del gene polymorphism and its elevated circulating levels are associated with gastric cancer, particularly with Helicobacter pylori infection and intestinal metaplasia.

Authors:  Sushil Kumar; Niraj Kumari; Rama D Mittal; Uday C Ghoshal
Journal:  Gastric Cancer       Date:  2015-10-20       Impact factor: 7.370

2.  Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysis.

Authors:  Jennifer M Yeh; Chin Hur; Zachary Ward; Deborah Schrag; Sue J Goldie
Journal:  Gut       Date:  2015-03-16       Impact factor: 23.059

Review 3.  Potential prognostic, diagnostic and therapeutic markers for human gastric cancer.

Authors:  Ming-Ming Tsai; Chia-Siu Wang; Chung-Ying Tsai; Hsiang-Cheng Chi; Yi-Hsin Tseng; Kwang-Huei Lin
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

Review 4.  Screening for and surveillance of gastric cancer.

Authors:  Debora Compare; Alba Rocco; Gerardo Nardone
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

5.  Serum pepsinogen 1 and anti-Helicobacter pylori IgG antibodies as predictors of gastric cancer risk in Finnish males.

Authors:  M Song; M C Camargo; S J Weinstein; G Murphy; N D Freedman; J Koshiol; R Z Stolzenberg-Solomon; C C Abnet; S Männistö; D Albanes; C S Rabkin
Journal:  Aliment Pharmacol Ther       Date:  2017-12-15       Impact factor: 8.171

Review 6.  Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels - "ABC method".

Authors:  Kazumasa Miki
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2011       Impact factor: 3.493

Review 7.  Functional, Diagnostic and Therapeutic Aspects of Gastrointestinal Hormones.

Authors:  Monjur Ahmed; Sarah Ahmed
Journal:  Gastroenterology Res       Date:  2019-10-04

8.  Combination of Serum Test and Questionnaire in Early Gastric Cancer Screening.

Authors:  Qiang Li; Yibing Liu; Zhe Meng; Qingfeng Ge; Liyan Zhao; Huiying Chu; Xiaomin Li; Jingli Chen; Qingju Meng
Journal:  Iran J Public Health       Date:  2022-08       Impact factor: 1.479

Review 9.  Molecular Alterations in Gastric Intestinal Metaplasia.

Authors:  Paulius Jonaitis; Limas Kupcinskas; Juozas Kupcinskas
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.